Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yufei Liu

Showing results (521-530 of 524) with videos related to

Pageof 53
Sort By:
You have reached the last page of results.This site can display upto 524 results.
Cancer Discovery|April 29, 2025
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung CancerEverett J Moding, Mohammad Shahrokh Esfahani, Cheng Jin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2024
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLCAmin H Nassar, Ritujith Jayakrishnan, Jamie Feng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2024
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort StudyAmin H Nassar, So Yeon Kim, Jacqueline V Aredo, et al.
Genetics|July 16, 2013
A new system for comparative functional genomics of Saccharomyces yeastsAmy A Caudy, Yuanfang Guan, Yue Jia, et al.
Pageof 53

Showing results (521-530 of 524) with videos related to

Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 524 results.
Cancer Discovery|April 29, 2025
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung CancerEverett J Moding, Mohammad Shahrokh Esfahani, Cheng Jin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2024
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLCAmin H Nassar, Ritujith Jayakrishnan, Jamie Feng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2024
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort StudyAmin H Nassar, So Yeon Kim, Jacqueline V Aredo, et al.
Genetics|July 16, 2013
A new system for comparative functional genomics of Saccharomyces yeastsAmy A Caudy, Yuanfang Guan, Yue Jia, et al.
Pageof 53